155 related articles for article (PubMed ID: 26835011)
1. PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells.
Xie Y; Bayakhmetov S
Mol Clin Oncol; 2016 Jan; 4(1):13-17. PubMed ID: 26835011
[TBL] [Abstract][Full Text] [Related]
2. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Holder SL; Abdulkadir SA
Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
[TBL] [Abstract][Full Text] [Related]
3. Using insights into Pim1 structure to design new anticancer drugs.
Schenone S; Tintori C; Botta M
Curr Pharm Des; 2010; 16(35):3964-78. PubMed ID: 21158732
[TBL] [Abstract][Full Text] [Related]
4. PIM1 kinase as a target for cancer therapy.
Merkel AL; Meggers E; Ocker M
Expert Opin Investig Drugs; 2012 Apr; 21(4):425-36. PubMed ID: 22385334
[TBL] [Abstract][Full Text] [Related]
5. Identification of quinones as novel PIM1 kinase inhibitors.
Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
[TBL] [Abstract][Full Text] [Related]
6. The role of PIM1/PIM2 kinases in tumors of the male reproductive system.
Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106
[TBL] [Abstract][Full Text] [Related]
7. Insights from Pim1 structure for anti-cancer drug design.
Ogawa N; Yuki H; Tanaka A
Expert Opin Drug Discov; 2012 Dec; 7(12):1177-92. PubMed ID: 23004574
[TBL] [Abstract][Full Text] [Related]
8. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.
Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M
Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
[TBL] [Abstract][Full Text] [Related]
10. Pim1 kinase regulates c-Kit gene translation.
An N; Cen B; Cai H; Song JH; Kraft A; Kang Y
Exp Hematol Oncol; 2016; 5():31. PubMed ID: 28042518
[TBL] [Abstract][Full Text] [Related]
11. Nuclear PIM1 confers resistance to rapamycin-impaired endothelial proliferation.
Walpen T; Kalus I; Schwaller J; Peier MA; Battegay EJ; Humar R
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):24-30. PubMed ID: 23131564
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.
Wang Y; Zhou X; Shan B; Han J; Wang F; Fan X; Lv Y; Chang L; Liu W
Mol Med Rep; 2015 Nov; 12(5):6491-500. PubMed ID: 26352175
[TBL] [Abstract][Full Text] [Related]
13. PIM kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract][Full Text] [Related]
14. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
15. A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.
Zhang X; Su Q; Zhang Y; Rong R; Chen S; He L; Zhuang W; Li B
Ann Hematol; 2024 Mar; ():. PubMed ID: 38424303
[TBL] [Abstract][Full Text] [Related]
16. Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2.
Wang BW; Huang CH; Liu LC; Cheng FJ; Wei YL; Lin YM; Wang YF; Wei CT; Chen Y; Chen YJ; Huang WC
Front Pharmacol; 2021; 12():614673. PubMed ID: 34267653
[TBL] [Abstract][Full Text] [Related]
17. Pim-1 kinase as cancer drug target: An update.
Tursynbay Y; Zhang J; Li Z; Tokay T; Zhumadilov Z; Wu D; Xie Y
Biomed Rep; 2016 Feb; 4(2):140-146. PubMed ID: 26893828
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus.
Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Ferrer I; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Oncotarget; 2017 Aug; 8(35):58872-58886. PubMed ID: 28938604
[TBL] [Abstract][Full Text] [Related]
19. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
[TBL] [Abstract][Full Text] [Related]
20. The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition.
Mologni L; Magistroni V; Casuscelli F; Montemartini M; Gambacorti-Passerini C
J Cancer; 2017; 8(1):140-145. PubMed ID: 28123608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
